Wanvisa Udomsinprasert

20PUBLICATIONS
11CO-AUTHORS
Haematological tumoursMolecular targetsDisease surveillancePredictive and prognostic markersNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 30, 2026
Hepatic T-cell dysfunction in chronic liver disease and hepatocellular carcinoma: a spatial systems immunology framework for precision immunotherapy.

|Jun 08, 2026
CYP2E1 and CYP2D6 in Anti-Tuberculosis Drug-Induced Liver Injury: Mechanisms, Epigenetic Regulation, and Translational Implications.

|Jan 30, 2026
Prevalence of Severe Thalassemia and Performance of Prenatal Screening Tests Among Pregnant Women at Siriraj Thalassemia Center in Thailand.

Kwandao Malasai, Usa Chaikledkaew, Pattarawalai Talungchit

|Jul 22, 2025
Long interspersed nuclear element 1 methylation in non-small cell lung cancer: implications for diagnosis, prognosis, and therapeutic targeting.

Dileesha Prabani Wanasundara Arachchillage, Wanvisa Udomsinprasert

|Mar 26, 2025
Association of NAT2 promoter hypermethylation with susceptibility to hepatotoxicity due to antituberculosis drugs and biomarker potential.

Jiraphun Jittikoon, Wacharapol Saengsiwaritt, Noppadol Chanhom

|Nov 03, 2024
Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer.

Narumol Trachu, Thanyanan Reungwetwattana, Jennis Meanwatthana

Pageof 4

Frequent Collaborators

3 joint publications

Sittisak Honsawek

2 joint publications

Jiraphun Jittikoon

2 joint publications

Usa Chaikledkaew

2 joint publications

Tachatra Ungsudechachai